Dongfeng Cheng

1.7k total citations
28 papers, 863 citations indexed

About

Dongfeng Cheng is a scholar working on Oncology, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Dongfeng Cheng has authored 28 papers receiving a total of 863 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Oncology, 15 papers in Surgery and 12 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Dongfeng Cheng's work include Pancreatic and Hepatic Oncology Research (20 papers), Neuroendocrine Tumor Research Advances (8 papers) and Pancreatitis Pathology and Treatment (8 papers). Dongfeng Cheng is often cited by papers focused on Pancreatic and Hepatic Oncology Research (20 papers), Neuroendocrine Tumor Research Advances (8 papers) and Pancreatitis Pathology and Treatment (8 papers). Dongfeng Cheng collaborates with scholars based in China and United States. Dongfeng Cheng's co-authors include Chenghong Peng, Qian Zhan, Xiaxing Deng, Baiyong Shen, Hao Chen, Zhichong Wu, Weishen Wang, Baiyong Shen, Xiaxing Deng and Junjie Xie and has published in prestigious journals such as Cancer Research, Molecular Cancer and Journal of Cellular Biochemistry.

In The Last Decade

Dongfeng Cheng

28 papers receiving 851 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Dongfeng Cheng China 13 470 462 347 256 175 28 863
Meihai Deng China 15 214 0.5× 299 0.6× 96 0.3× 146 0.6× 143 0.8× 45 667
Yasser Ged United States 12 169 0.4× 244 0.5× 212 0.6× 87 0.3× 60 0.3× 59 549
Toshikatsu Fukuda Japan 12 93 0.2× 268 0.6× 362 1.0× 297 1.2× 106 0.6× 44 676
Yu‐Suo Tong China 13 807 1.7× 744 1.6× 268 0.8× 234 0.9× 128 0.7× 24 1.1k
Osamu Okochi Japan 9 116 0.2× 205 0.4× 183 0.5× 135 0.5× 105 0.6× 26 518
Paul A. Toste United States 13 220 0.5× 225 0.5× 390 1.1× 208 0.8× 120 0.7× 22 638
Justin S. Gundara Australia 13 328 0.7× 316 0.7× 141 0.4× 221 0.9× 83 0.5× 52 749
Hiroyuki Endo Japan 9 419 0.9× 434 0.9× 120 0.3× 184 0.7× 75 0.4× 28 791
Yi‐Qun Che China 13 281 0.6× 311 0.7× 125 0.4× 62 0.2× 31 0.2× 34 519
Francesco Puleo Belgium 11 238 0.5× 181 0.4× 476 1.4× 188 0.7× 77 0.4× 19 668

Countries citing papers authored by Dongfeng Cheng

Since Specialization
Citations

This map shows the geographic impact of Dongfeng Cheng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dongfeng Cheng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dongfeng Cheng more than expected).

Fields of papers citing papers by Dongfeng Cheng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dongfeng Cheng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dongfeng Cheng. The network helps show where Dongfeng Cheng may publish in the future.

Co-authorship network of co-authors of Dongfeng Cheng

This figure shows the co-authorship network connecting the top 25 collaborators of Dongfeng Cheng. A scholar is included among the top collaborators of Dongfeng Cheng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dongfeng Cheng. Dongfeng Cheng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhang, Qingjian, Dongfeng Cheng, Xianghua Tang, et al.. (2025). Functional Characterization of GNA1 as a Serotonin N ‐Acetyltransferase Reveals a Key Role in the Serotonin to Melatonin Pathway in Saccharomyces cerevisiae. Journal of Pineal Research. 77(4). e70065–e70065. 1 indexed citations
2.
Zhou, Yiran, Jiabin Jin, Jun Wang, et al.. (2023). TP53 missense mutation reveals gain-of-function properties in small-sized KRAS transformed pancreatic ductal adenocarcinoma. Journal of Translational Medicine. 21(1). 872–872. 4 indexed citations
3.
Chen, Haoda, Jingyu Zhong, Chao Wang, et al.. (2023). Enhancement pattern of the pancreatic parenchyma predicts postpancreatectomy acute pancreatitis after pancreaticoduodenectomy. European Radiology. 34(1). 6–15. 4 indexed citations
4.
Chen, Haoda, Weishen Wang, Siyi Zou, et al.. (2022). Serum lipase on postoperative day one is a strong predictor of clinically relevant pancreatic fistula after pancreaticoduodenectomy: A retrospective cohort. Pancreatology. 22(6). 810–816. 9 indexed citations
5.
Wang, Weishen, Dongfeng Cheng, Jiancheng Wang, et al.. (2021). Original study: The rescue staging for pancreatic ductal adenocarcinoma with inadequate examined lymph nodes. Pancreatology. 21(4). 724–730. 3 indexed citations
6.
Wen, Chenlei, Xiaxing Deng, Song Xue, et al.. (2020). Tumor copy number instability is a significant predictor for late recurrence after radical surgery of pancreatic ductal adenocarcinoma. Cancer Medicine. 9(20). 7626–7636. 2 indexed citations
7.
Gu, Jiangning, Zhiwei Xu, Yang Ma, et al.. (2020). Surgical resection of metastatic pancreatic cancer: is it worth it?—a 15-year experience at a single Chinese center. Journal of Gastrointestinal Oncology. 11(2). 319–328. 8 indexed citations
8.
Chen, Haoda, Weishen Wang, Xiayang Ying, et al.. (2019). Predictive factors for postoperative pancreatitis after pancreaticoduodenectomy: A single-center retrospective analysis of 1465 patients. Pancreatology. 20(2). 211–216. 32 indexed citations
9.
Zhou, Yiran, Wei Wang, Hao Chen, et al.. (2019). Should a standard lymphadenectomy include the No. 9 lymph nodes for body and tail pancreatic ductal adenocarcinoma?. Pancreatology. 19(3). 414–418. 8 indexed citations
10.
Jin, Jiabin, Yi Yang, Yusheng Shi, et al.. (2019). Robotic pancreatectomy for solid pseudopapillary tumors in the pancreatic head: A propensity score-matched comparison and analysis from a single center. Asian Journal of Surgery. 43(1). 354–361. 17 indexed citations
11.
Ma, Yang, Yiran Zhou, Xiayang Ying, et al.. (2019). Resection of pancreatic metastatic renal cell carcinoma: experience and long-term survival outcome from a large center in China. International Journal of Clinical Oncology. 24(6). 686–693. 12 indexed citations
12.
Gu, Jiangning, Wei Xu, Chenghong Peng, et al.. (2019). Perineural invasion is related to p38 mitogen‐activated protein kinase pathway activation and promotes tumor growth and chemoresistance in pancreatic cancer. Journal of Cellular Biochemistry. 120(7). 11775–11783. 4 indexed citations
13.
Li, Hongzhe, Xinjing Wang, Chenlei Wen, et al.. (2017). Long noncoding RNA NORAD, a novel competing endogenous RNA, enhances the hypoxia-induced epithelial-mesenchymal transition to promote metastasis in pancreatic cancer. Molecular Cancer. 16(1). 169–169. 192 indexed citations
14.
Chen, Shi, Qian Zhan, Jiabin Jin, et al.. (2016). Robot-assisted laparoscopic versus open middle pancreatectomy: short-term results of a randomized controlled trial. Surgical Endoscopy. 31(2). 962–971. 38 indexed citations
15.
Li, Tao, Junjie Xie, Chuan Shen, et al.. (2015). Amplification of Long Noncoding RNA ZFAS1 Promotes Metastasis in Hepatocellular Carcinoma. Cancer Research. 75(15). 3181–3191. 260 indexed citations
16.
Wang, Xinjing, Zhen Huo, Chenlei Wen, et al.. (2015). Robot-Assisted Middle Pancreatectomy for Elderly Patients: Our Initial Experience. Medical Science Monitor. 21. 2851–2860. 9 indexed citations
17.
Zhang, Feixue, Dongfeng Cheng, Mei Wu, Ling Ge, & Xiangxing Ma. (2014). Diagnosis of infantile myofibromatosis with pseudo-ulcerated plaque using prenatal ultrasound: A case report. Experimental and Therapeutic Medicine. 8(6). 1769–1771. 4 indexed citations
18.
Cheng, Kun, et al.. (2013). Middle-preserving pancreatectomy: report of two cases and review of the literature. World Journal of Surgical Oncology. 11(1). 106–106. 18 indexed citations
19.
Dong, Yadong, Long Cui, Chenghong Peng, et al.. (2012). Expression and clinical significance of HMGB1 in human liver cancer: Knockdown inhibits tumor growth and metastasis in vitro and in vivo. Oncology Reports. 29(1). 87–94. 47 indexed citations
20.
Ye, Jinhua, Mingzhe Ma, Dongfeng Cheng, et al.. (2012). Solid‐pseudopapillary tumor of the pancreas: Clinical features, pathological characteristics, and origin. Journal of Surgical Oncology. 106(6). 728–735. 34 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Meihai Deng Breakdown of academic impact, for papers by Yasser Ged Breakdown of academic impact, for papers by Toshikatsu Fukuda Breakdown of academic impact, for papers by Yu‐Suo Tong Breakdown of academic impact, for papers by Osamu Okochi Breakdown of academic impact, for papers by Paul A. Toste Breakdown of academic impact, for papers by Justin S. Gundara Breakdown of academic impact, for papers by Hiroyuki Endo Breakdown of academic impact, for papers by Yi‐Qun Che Breakdown of academic impact, for papers by Francesco Puleo
Rankless by CCL
2026